BACKGROUND: Brugada syndrome (BS) is associated with an increased risk of sudden
cardiac death (SCD) caused by ventricular tachyarrhythmia. Thus, implantable cardioverter …

Implantable cardioverter defibrillator implantation in Brugada syndrome Arrhythmic SCD is a
significant cause of mortality, 5–15% of people with SCD have no structural abnormalities …

In this issue of Circulation, a group of experts in ablation therapy and Brugada syndrome
report the longawaited results of the BRAVO study (Brugada Ablation of VF Substrate …

A patient's ICD refusal poses a relevant therapeutic challenge for cardiologists managing 4
patients with Brugada syndrome (BrS) and a clear indication to implantable cardioverter-5 …

Objective The present study aimed at investigating the incidence of paroxysmal atrial
fibrillation in 10 patients with spontaneous or induced type 1 electrocardiographic pattern of …

The use of an implantable cardiac defibrillator has been advocated as the only effective
treatment for the management of ventricular fibrillation (VF) in patients with Brugada …

Brugada syndrome (BrS) is an “inherited” condition characterized by predisposition to
syncope and cardiac arrest, predominantly during sleep. The prevalence is∼ 1: 2,000, and …

Brugada syndrome is a congenital electrical disorder characterised by the appearance of
distinctive QRST-T patterns in the right precordial leads and an increased risk of sudden …

Clinical manifestation of Brugada syndrome (BrS) mainly results from polymorphic
ventricular arrhythmias and includes sudden cardiac arrest (SCA). The Brugada sign …

Purpose The aim of this study was to assess the prevalence of atrial fibrillation (AF) in
patients with Brugada syndrome (BrS) and their clinical characteristics in Taiwan. Methods …